Detalhe da pesquisa
1.
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins.
Annu Rev Nutr
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38635875
2.
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
Eur Heart J
; 44(39): 4186-4195, 2023 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37358553
3.
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Diabetologia
; 66(12): 2307-2319, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37775612
4.
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
J Intern Med
; 291(2): 218-223, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34411351
5.
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease.
Curr Atheroscler Rep
; 24(3): 133-142, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35175548
6.
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Arterioscler Thromb Vasc Biol
; 41(2): 962-975, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33356392
7.
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
Eur Heart J
; 42(47): 4791-4806, 2021 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34472586
8.
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
Diabetes Obes Metab
; 23(5): 1191-1201, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33502078
9.
Strategies to alter the trajectory of atherosclerotic cardiovascular disease.
Curr Opin Lipidol
; 30(6): 438-445, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31609725
10.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Cardiovasc Diabetol
; 18(1): 71, 2019 06 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31164165
11.
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.
Curr Atheroscler Rep
; 21(8): 27, 2019 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31111320
12.
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
Curr Atheroscler Rep
; 21(10): 41, 2019 07 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31350612
13.
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
JAMA
; 321(4): 364-373, 2019 01 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30694319
14.
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.
JAMA
; 322(14): 1381-1391, 2019 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31475726
15.
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Circulation
; 136(20): 1878-1891, 2017 Nov 14.
Artigo
Inglês
| MEDLINE | ID: mdl-28877913
16.
Association of oily fish intake, sex, age, BMI and APOE genotype with plasma long-chain n-3 fatty acid composition.
Br J Nutr
; 120(1): 23-32, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29729672
17.
Determinants of Achieved LDL Cholesterol and "Non-HDL" Cholesterol in the Management of Dyslipidemias.
Curr Cardiol Rep
; 20(8): 60, 2018 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29904807
18.
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Eur Heart J
; 38(32): 2459-2472, 2017 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-28444290
19.
Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.
Circulation
; 133(11): 1073-80, 2016 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26864092
20.
Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
Ann Rheum Dis
; 76(11): 1949-1952, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28916714